These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33098770)

  • 1. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.
    Guedj F; Siegel AE; Pennings JLA; Alsebaa F; Massingham LJ; Tantravahi U; Bianchi DW
    Am J Hum Genet; 2020 Nov; 107(5):911-931. PubMed ID: 33098770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
    Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.
    Guedj F; Pennings JL; Ferres MA; Graham LC; Wick HC; Miczek KA; Slonim DK; Bianchi DW
    Am J Med Genet A; 2015 Sep; 167A(9):1993-2008. PubMed ID: 25975229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
    Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
    Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbation of the immune cells and prenatal neurogenesis by the triplication of the Erg gene in mouse models of Down syndrome.
    Ishihara K; Shimizu R; Takata K; Kawashita E; Amano K; Shimohata A; Low D; Nabe T; Sago H; Alexander WS; Ginhoux F; Yamakawa K; Akiba S
    Brain Pathol; 2020 Jan; 30(1):75-91. PubMed ID: 31206867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome.
    Guedj F; Pennings JL; Massingham LJ; Wick HC; Siegel AE; Tantravahi U; Bianchi DW
    Sci Rep; 2016 Sep; 6():32353. PubMed ID: 27586445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.
    Goodliffe JW; Olmos-Serrano JL; Aziz NM; Pennings JL; Guedj F; Bianchi DW; Haydar TF
    J Neurosci; 2016 Mar; 36(10):2926-44. PubMed ID: 26961948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal treatment of Down syndrome: a reality?
    Guedj F; Bianchi DW; Delabar JM
    Curr Opin Obstet Gynecol; 2014 Apr; 26(2):92-103. PubMed ID: 24573065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal treatment with preimplantation factor improves early postnatal neurogenesis and cognitive impairments in a mouse model of Down syndrome.
    Moreau M; Dard R; Madani A; Kandiah J; Kassis N; Ziga J; Castiglione H; Day S; Bourgeois T; Matrot B; Vialard F; Janel N
    Cell Mol Life Sci; 2024 May; 81(1):215. PubMed ID: 38739166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.
    Hewitt CA; Ling KH; Merson TD; Simpson KM; Ritchie ME; King SL; Pritchard MA; Smyth GK; Thomas T; Scott HS; Voss AK
    PLoS One; 2010 Jul; 5(7):e11561. PubMed ID: 20661276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks.
    Ling KH; Hewitt CA; Tan KL; Cheah PS; Vidyadaran S; Lai MI; Lee HC; Simpson K; Hyde L; Pritchard MA; Smyth GK; Thomas T; Scott HS
    BMC Genomics; 2014 Jul; 15(1):624. PubMed ID: 25052193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of spatial memory accuracy improved by Cbr1 copy number resumption and GABA
    Arima-Yoshida F; Raveau M; Shimohata A; Amano K; Fukushima A; Watanave M; Kobayashi S; Hattori S; Usui M; Sago H; Mataga N; Miyakawa T; Yamakawa K; Manabe T
    Sci Rep; 2020 Aug; 10(1):14187. PubMed ID: 32843708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal Natural History of the Ts1Cje Mouse Model of Down Syndrome: Growth Restriction, Early Mortality, Heart Defects, and Delayed Development.
    Ferrés MA; Bianchi DW; Siegel AE; Bronson RT; Huggins GS; Guedj F
    PLoS One; 2016; 11(12):e0168009. PubMed ID: 27930746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
    Gault VA; Lennox R; Flatt PR
    Diabetes Obes Metab; 2015 Apr; 17(4):403-13. PubMed ID: 25580570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.
    Day SM; Yang W; Wang X; Stern JE; Zhou X; Macauley SL; Ma T
    eNeuro; 2019; 6(2):. PubMed ID: 31040160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome.
    Martínez-Cué C; Martínez P; Rueda N; Vidal R; García S; Vidal V; Corrales A; Montero JA; Pazos Á; Flórez J; Gasser R; Thomas AW; Honer M; Knoflach F; Trejo JL; Wettstein JG; Hernández MC
    J Neurosci; 2013 Feb; 33(9):3953-66. PubMed ID: 23447605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.